# Network pharmacognosy of Galphimia glauca: Mapping the molecular landscape of a traditional Mexican medicinal plant

## TL;DR

This study uses network pharmacognosy to explore how the Mexican medicinal plant Galphimia glauca interacts with human proteins, revealing its potential as a multi-target therapeutic agent.

## Contribution

The study introduces a network pharmacognosy approach to map the molecular mechanisms of Galphimia glauca’s bioactive compounds.

## Key findings

- Galphimines A-I target 214 human proteins, with 41 shared across all compounds.
- Key proteins like SRC, MTOR, and MAPK3 are central to cell growth and immune regulation pathways.
- Network modules are linked to cell survival, immune response, and inflammation, aligning with the plant’s traditional uses.

## Abstract

This study explores the pharmacological landscape of Galphimia glauca, a traditional Mexican medicinal plant known for its sedative and anti-inflammatory effects. Using network pharmacognosy, we analyzed the interactions of G. glauca’s bioactive compounds, Galphimines A-I, with human protein targets. SwissTargetPrediction identified 214 unique protein targets across the galphimines, revealing a core-periphery structure in a bipartite network where 41 targets are shared among all compounds. Further interaction analysis using STRING-DB generated a dense protein-protein interaction network comprising 1,386 connections. Centrality analysis highlighted proteins such as SRC, MTOR, and MAPK3 as key nodes involved in cell growth, proliferation, and immune regulation pathways, suggesting these as pivotal mediators of G. glauca’s pharmacological effects. Community detection with the Walktrap algorithm further segmented the network into functionally relevant modules linked to cell survival, immune response, and inflammation, reflecting the therapeutic effects historically attributed to G. glauca. Our findings underscore the plant’s multi-target therapeutic potential and highlight the value of network-based approaches in understanding traditional medicine. This work lays the groundwork for further studies aimed at refining therapeutic strategies based on G. glauca’s bioactive compounds and suggests network pharmacognosy as a promising tool for assessing other traditional medicinal plants.